{
    "code": "01016868",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01016868",
    "time": "2020-02-25 02:38:20",
    "許可證字號": "衛署藥製字第016868號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/05\/25",
    "發證日期": "68\/03\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00101686800",
    "中文品名": "&quot;台裕&quot; 賜爾康注射液（普斯克）",
    "英文品名": "HYOSCON INJECTION (SCOPOLAMINE BUTYLBROMIDE)&quot;TAI YU&quot;",
    "適應症": "胃腸管之痙攣（胃潰瘍、十二指腸潰瘍、胃炎、賁門痙攣、腸疝痛、空腸潰瘍）膽管之痙攣及運動障礙（膽囊炎、膽管炎、膽石症、膽石疝痛）女性生殖器的痙攣（分娩時子宮下部弛緩遲延、痙攣性月經困難）",
    "劑型": "270注射劑",
    "包裝": "1ml安瓿瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "1402206200  台裕化學製藥廠股份有限公司",
        "申請商地址": "新竹縣竹東鎮員山路１１巷１３弄１號",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208001210",
            "成分名稱": "BUTYLSCOPOLAMINE BROMIDE (EQ TO HYOSCINE-N-BUTYLBROMIDE)",
            "含量描述": "",
            "含量": "20.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "1ml",
        "特殊劑型": "",
        "顏色": "無色或微黃色",
        "特殊氣味": "無",
        "刻痕": "無",
        "形狀": "長圓柱形",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "[外觀]016868賜爾康注射液(普斯克)(1毫升)-104-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01016868&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "016868賜爾康-D-20180528-107-07-12(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01016868&Seq=007&Type=9"
        },
        {
            "title": "[外盒]016868賜爾康注射液(普斯克)(1毫升)-104-12-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01016868&Seq=002&Type=8"
        }
    ]
}